Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2014-12-31Clinical Trial Update: Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842) [Phase 2]
This Phase 2 clinical trial safety update reports on the safety of Org 34517 900 mg in patients who had previously received Org 34517 in an …
-
CLINICAL_TRIALS research · 2014-12-31Clinical Trial Update: Controlled Study About Implementation of a Computerized Depression Guideline in Primary Care [NA]
A controlled clinical study update examining the implementation of a computerized depression guideline in primary care settings.
-
FDA approval · 2014-12-30FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) from Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Depression Related Improvement With Vardenafil for Erectile Response [Phase 3]
A Phase 3 trial evaluating vardenafil for erectile dysfunction with depression completed, reporting depression-related improvement in erecti…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder [NA]
An update indicates that a randomized trial comparing placebo without deception to a standard antidepressant for major depressive disorder h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Psychophysiological Correlates of Mindfulness Based Cognitive Therapy (MBCT) in Recurrent Depression [NA]
A completed clinical trial investigating psychophysiological correlates of Mindfulness Based Cognitive Therapy (MBCT) in recurrent depressio…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Functional and Neurochemical Brain Changes Bipolar Depression
The clinical trial examining functional and neurochemical brain changes in bipolar depression has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Coping Intervention After Embryo Transfer [NA]
A completed clinical trial evaluated a coping intervention after embryo transfer, with results posted in 2014 and outcomes related to anxiet…
-
FDA approval · 2014-12-20FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL from Actavis Pharma, Inc., formalizing approval of an extended-releas…
-
FDA approval · 2014-12-19FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for a generic olanzapine and fluoxetine fixed-dose product, expanding access to the olanzapine/…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Waitlist-Controlled Trial of the Unified Protocol for the Treatment of Emotional Disorders in Adolescents [NA]
The document reports the completion of a waitlist-controlled clinical trial evaluating the Unified Protocol for treating emotional disorders…
-
FDA approval · 2014-12-19FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for a generic fixed-dose combination of olanzapine and fluoxetine (olanzapine and fluoxetine).
-
FDA approval · 2014-12-18FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original application for a generic bupropion hydrochloride product. The approval covers i…
-
FDA approval · 2014-12-17FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) by Viatris Specialty LLC. The action is to modify labelin…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas [Phase 2]
Phase 2 trial evaluating telephone-administered psychotherapy for depression in rural-area veterans; results were posted after completion.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse [NA]
This clinical trial update reports the completion and posted results of a UT Southwestern study on sequential treatment for pediatric major …
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury [Phase 2]
Phase 2 feasibility study evaluating duloxetine for depression in patients with traumatic brain injury; the trial was terminated and results…
-
CLINICAL_TRIALS research · 2014-12-17Clinical Trial Update: Evaluating Neuromodulation Technologies in Early Recovery [NA]
Clinical trial update on neuromodulation technologies being evaluated for early recovery, with conditions including Depression, Anxiety diso…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Preventing Health Disparities in Hispanic Youth [NA]
A completed clinical trial conducted by the University of Miami aimed at preventing health disparities in Hispanic youth, with conditions in…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression [NA]
This completed clinical trial compared three electroconvulsive therapy techniques for treating major depressive disorder. The study status w…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Depression Management at the Workplace [NA]
The study on depression management in the workplace conducted by Florida State University has completed. The record provides basic trial inf…
-
CLINICAL_TRIALS research · 2014-12-15Clinical Trial Update: Brain Imaging Techniques That Predict Antidepressant Responsiveness [NA]
A completed clinical trial from the University of Wisconsin investigated brain imaging techniques to predict antidepressant responsiveness i…
-
FDA approval · 2014-12-13FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Perphenazine and Amitriptyline Hydrochloride product manufactured by Mylan Pharmac…
-
FDA approval · 2014-12-13FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (ESCITSLOPRAM), a generic antidepressant, bringing a generic v…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Evaluation of the Effectiveness of a Web-based Treatment Program for Depression for the Reduction of Depressive Symptoms [NA]
This clinical trial evaluated a web-based treatment program for reducing depressive symptoms in depression and has completed.